• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

气道刷培养的气道上皮细胞中顶端氯离子浓度对 CFTR 调节反应测量的影响。

Effect of apical chloride concentration on the measurement of responses to CFTR modulation in airway epithelia cultured from nasal brushings.

机构信息

Department of Pediatrics, National Jewish Health, Denver, CO, USA.

Department of Pediatrics, Anschutz Medical Center, University of Colorado Denver, Aurora, CO, USA.

出版信息

Physiol Rep. 2020 Oct;8(19):e14603. doi: 10.14814/phy2.14603.

DOI:10.14814/phy2.14603
PMID:33038073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7547589/
Abstract

INTRODUCTION

One method for assessing the in vitro response to CFTR-modulating compounds is by analysis of epithelial monolayers in an Ussing chamber, where the apical and basolateral surfaces are isolated and the potential difference, short-circuit current, and transepithelial resistance can be monitored. The effect of a chloride ion gradient across airway epithelia on transepithelial chloride transport and the magnitude of CFTR modulator efficacy were examined.

METHODS

CFTR-mediated changes in the potential difference and transepithelial currents of primary human nasal epithelial cell cultures were quantified in Ussing chambers with either symmetrical solutions or reduced chloride solutions in the apical chamber. CFTR activity in homozygous F508del CFTR epithelia was rescued by treatment with VX-661, C4/C18, 4-phenylbutyrate (4-PBA) for 24 hr at 37°C or by incubation at 29°C for 48 hr.

RESULTS

Imposing a chloride gradient increased CFTR-mediated and CaCC-mediated ion transport. Treatment of F508del CFTR homozygous cells with CFTR modulating compounds increased CFTR activity, which was significantly more evident in the presence of a chloride gradient. This observation was recapitulated with temperature-mediated F508del CFTR correction.

CONCLUSIONS

Imposing a chloride gradient during Ussing chamber measurements resulted in increased CFTR-mediated ion transport in expanded non-CF and F508del CFTR homozygous epithelia. In F508del CFTR homozygous epithelia, the magnitude of response to CFTR modulating compounds or low temperature was greater when assayed with a chloride gradient compared to symmetrical chloride, resulting in an apparent increase in measured efficacy. Future work may direct which methodologies utilized to quantify CFTR modulator response in vitro are most appropriate for the estimation of in vivo efficacy.

摘要

简介

评估 CFTR 调节剂体外反应的一种方法是通过在 Ussing 室中分析上皮单层,其中隔离了顶侧和基底外侧表面,可以监测电势差、短路电流和跨上皮电阻。本文研究了气道上皮氯离子梯度对跨上皮氯离子转运的影响以及 CFTR 调节剂功效的大小。

方法

在 Ussing 室中,使用顶侧腔中具有对称溶液或降低氯离子溶液的方法,对原代人鼻上皮细胞培养物中 CFTR 介导的电势差和跨上皮电流变化进行定量分析。用 VX-661、C4/C18、4-苯丁酸(4-PBA)处理 37°C 24 小时或在 29°C 孵育 48 小时可恢复纯合 F508del CFTR 上皮中的 CFTR 活性。

结果

施加氯离子梯度可增加 CFTR 介导和 CaCC 介导的离子转运。用 CFTR 调节剂处理 F508del CFTR 纯合细胞可增加 CFTR 活性,在存在氯离子梯度的情况下,这一作用更为明显。这一观察结果与通过温度介导的 F508del CFTR 校正得到了重现。

结论

在 Ussing 室测量过程中施加氯离子梯度会导致非 CF 和 F508del CFTR 纯合上皮中 CFTR 介导的离子转运增加。在 F508del CFTR 纯合上皮中,与对称氯离子相比,用氯离子梯度检测 CFTR 调节剂或低温对 CFTR 调节剂的反应幅度更大,从而导致测量功效的表观增加。未来的研究可能会指导在体外量化 CFTR 调节剂反应的方法中,哪种方法最适合估计体内疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e44b/7547589/6515f3258435/PHY2-8-e14603-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e44b/7547589/2c5beb6b5991/PHY2-8-e14603-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e44b/7547589/e978316f1298/PHY2-8-e14603-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e44b/7547589/bc7b62198874/PHY2-8-e14603-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e44b/7547589/1845b01a9dc1/PHY2-8-e14603-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e44b/7547589/eed69f71d72b/PHY2-8-e14603-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e44b/7547589/6515f3258435/PHY2-8-e14603-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e44b/7547589/2c5beb6b5991/PHY2-8-e14603-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e44b/7547589/e978316f1298/PHY2-8-e14603-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e44b/7547589/bc7b62198874/PHY2-8-e14603-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e44b/7547589/1845b01a9dc1/PHY2-8-e14603-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e44b/7547589/eed69f71d72b/PHY2-8-e14603-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e44b/7547589/6515f3258435/PHY2-8-e14603-g006.jpg

相似文献

1
Effect of apical chloride concentration on the measurement of responses to CFTR modulation in airway epithelia cultured from nasal brushings.气道刷培养的气道上皮细胞中顶端氯离子浓度对 CFTR 调节反应测量的影响。
Physiol Rep. 2020 Oct;8(19):e14603. doi: 10.14814/phy2.14603.
2
Extracellular phosphate enhances the function of F508del-CFTR rescued by CFTR correctors.细胞外磷酸盐增强 CFTR 校正剂拯救的 F508del-CFTR 的功能。
J Cyst Fibros. 2021 Sep;20(5):843-850. doi: 10.1016/j.jcf.2021.04.013. Epub 2021 May 18.
3
Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators.囊性纤维化患者鼻黏膜上皮细胞中 CFTR 功能的校正可预测 CFTR 调节剂对呼吸功能的改善。
Sci Rep. 2017 Aug 7;7(1):7375. doi: 10.1038/s41598-017-07504-1.
4
Measurements of Functional Responses in Human Primary Lung Cells as a Basis for Personalized Therapy for Cystic Fibrosis.测量人原代肺细胞的功能反应,作为囊性纤维化个体化治疗的基础。
EBioMedicine. 2014 Dec 17;2(2):147-53. doi: 10.1016/j.ebiom.2014.12.005. eCollection 2015.
5
Extent of rescue of F508del-CFTR function by VX-809 and VX-770 in human nasal epithelial cells correlates with SNP rs7512462 in SLC26A9 gene in F508del/F508del Cystic Fibrosis patients.VX-809 和 VX-770 对 F508del-CFTR 功能的挽救程度与 F508del/F508del 囊性纤维化患者 SLC26A9 基因中的 SNP rs7512462 相关。
Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1323-1331. doi: 10.1016/j.bbadis.2019.01.029. Epub 2019 Feb 1.
6
Pseudomonas aeruginosa Reduces VX-809 Stimulated F508del-CFTR Chloride Secretion by Airway Epithelial Cells.铜绿假单胞菌降低VX-809刺激的气道上皮细胞F508del-CFTR氯离子分泌。
PLoS One. 2015 May 27;10(5):e0127742. doi: 10.1371/journal.pone.0127742. eCollection 2015.
7
Correction of chloride transport and mislocalization of CFTR protein by vardenafil in the gastrointestinal tract of cystic fibrosis mice.瓦地那非纠正囊性纤维化小鼠胃肠道中氯离子转运和 CFTR 蛋白定位错误。
PLoS One. 2013 Oct 24;8(10):e77314. doi: 10.1371/journal.pone.0077314. eCollection 2013.
8
Measurements of spontaneous CFTR-mediated ion transport without acute channel activation in airway epithelial cultures after modulator exposure.在接触调节剂后,在气道上皮培养物中测量无急性通道激活的自发 CFTR 介导的离子转运。
Sci Rep. 2021 Nov 19;11(1):22616. doi: 10.1038/s41598-021-02044-1.
9
Characterization of primary rat nasal epithelial cultures in CFTR knockout rats as a model for CF sinus disease.以CFTR基因敲除大鼠的原代鼻上皮细胞培养物作为囊性纤维化鼻窦炎疾病模型的特征分析。
Laryngoscope. 2017 Nov;127(11):E384-E391. doi: 10.1002/lary.26720. Epub 2017 Aug 3.
10
Correlating genotype with phenotype using CFTR-mediated whole-cell Cl currents in human nasal epithelial cells.利用人鼻上皮细胞中CFTR介导的全细胞氯离子电流将基因型与表型相关联。
J Physiol. 2022 Mar;600(6):1515-1531. doi: 10.1113/JP282143. Epub 2021 Dec 8.

引用本文的文献

1
Culture conditions differentially regulate the inflammatory niche and cellular phenotype of tracheobronchial basal stem cells.培养条件差异性地调节气管支气管基底干细胞的炎症微环境和细胞表型。
Am J Physiol Lung Cell Mol Physiol. 2025 Apr 1;328(4):L538-L553. doi: 10.1152/ajplung.00293.2024. Epub 2025 Feb 21.
2
VX-770, C-A1, and Increased Intracellular cAMP Have Distinct Acute Impacts upon CFTR Activity.VX-770、C-A1以及细胞内cAMP水平升高对囊性纤维化跨膜传导调节因子(CFTR)活性具有不同的急性影响。
Int J Mol Sci. 2025 Jan 8;26(2):471. doi: 10.3390/ijms26020471.
3
The Functional Impact of VX-770 on the Cystic Fibrosis Transmembrane Conductance Regulator Is Enduring and Increases the Constitutive Activity of This Channel in Primary Airway Epithelia Generated from Healthy Donors.

本文引用的文献

1
Dissecting the cellular specificity of smoking effects and reconstructing lineages in the human airway epithelium.解析吸烟效应的细胞特异性并重建人类气道上皮中的谱系。
Nat Commun. 2020 May 19;11(1):2485. doi: 10.1038/s41467-020-16239-z.
2
Ivacaftor in cystic fibrosis with residual function: Lung function results from an N-of-1 study.依伐卡托特在有残留功能的囊性纤维化中的应用:一项 N-of-1 研究的肺功能结果。
J Cyst Fibros. 2020 Jan;19(1):91-98. doi: 10.1016/j.jcf.2019.09.013. Epub 2019 Nov 26.
3
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.
VX-770 对囊性纤维化跨膜电导调节剂的功能影响是持久的,并增加了源自健康供体的主要气道上皮中该通道的组成活性。
Biomolecules. 2024 Oct 29;14(11):1378. doi: 10.3390/biom14111378.
4
Culture Conditions Differentially Regulate the Inflammatory Niche and Cellular Phenotype of Tracheo-Bronchial Basal Stem Cells.培养条件差异性调节气管支气管基底干细胞的炎性微环境和细胞表型。
bioRxiv. 2024 Sep 5:2024.09.04.611264. doi: 10.1101/2024.09.04.611264.
5
Increased intracellular Cl concentration mediates neutrophil extracellular traps formation in atherosclerotic cardiovascular diseases.细胞内氯离子浓度增加介导动脉粥样硬化性心血管疾病中中性粒细胞胞外诱捕网的形成。
Acta Pharmacol Sin. 2022 Nov;43(11):2848-2861. doi: 10.1038/s41401-022-00911-9. Epub 2022 May 5.
6
Net benefit of ivacaftor during prolonged tezacaftor/elexacaftor exposure in vitro.体外延长 tezacaftor/elexacaftor 暴露时 ivacaftor 的净收益。
J Cyst Fibros. 2022 Jul;21(4):637-643. doi: 10.1016/j.jcf.2022.02.011. Epub 2022 Mar 2.
7
Receptor-mediated activation of CFTR via prostaglandin signaling pathways in the airway.气道中前列腺素信号通路介导的 CFTR 受体激活。
Am J Physiol Lung Cell Mol Physiol. 2022 Mar 1;322(3):L305-L314. doi: 10.1152/ajplung.00388.2021. Epub 2022 Jan 12.
8
Measurements of spontaneous CFTR-mediated ion transport without acute channel activation in airway epithelial cultures after modulator exposure.在接触调节剂后,在气道上皮培养物中测量无急性通道激活的自发 CFTR 介导的离子转运。
Sci Rep. 2021 Nov 19;11(1):22616. doi: 10.1038/s41598-021-02044-1.
9
Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment.依利卓(Elexacaftor)是一种 CFTR 增效剂,在急性和慢性治疗期间与 ivacaftor 协同作用。
Sci Rep. 2021 Oct 6;11(1):19810. doi: 10.1038/s41598-021-99184-1.
10
Nasal Epithelial Cell-Based Models for Individualized Study in Cystic Fibrosis.用于囊性纤维化个体化研究的鼻上皮细胞模型
Int J Mol Sci. 2021 Apr 24;22(9):4448. doi: 10.3390/ijms22094448.
依伐卡托与泰比卡托和艾克卡托三联复方药物治疗携带单个 F508del 突变的囊性纤维化
N Engl J Med. 2019 Nov 7;381(19):1809-1819. doi: 10.1056/NEJMoa1908639. Epub 2019 Oct 31.
4
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.在纯合子 F508del 突变的囊性纤维化患者中,elexacaftor 加 tezacaftor 加 ivacaftor 联合治疗方案的疗效和安全性:一项双盲、随机、3 期临床试验。
Lancet. 2019 Nov 23;394(10212):1940-1948. doi: 10.1016/S0140-6736(19)32597-8. Epub 2019 Oct 31.
5
The anion transporter SLC26A9 localizes to tight junctions and is degraded by the proteasome when co-expressed with F508del-CFTR.阴离子转运蛋白 SLC26A9 定位于紧密连接,当与 F508del-CFTR 共表达时,会被蛋白酶体降解。
J Biol Chem. 2019 Nov 29;294(48):18269-18284. doi: 10.1074/jbc.RA119.010192. Epub 2019 Oct 23.
6
Effectivenesss of ivacaftor in severe cystic fibrosis patients and non-G551D gating mutations.依伐卡托在重症囊性纤维化患者和非 G551D 门控突变中的疗效。
Pediatr Pulmonol. 2019 Sep;54(9):1398-1403. doi: 10.1002/ppul.24424. Epub 2019 Jun 25.
7
An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB).KLIMB 研究:在 2-5 岁有 CFTR 门控突变的 CF 患儿中开展 ivacaftor 的开放标签扩展研究,以启动治疗。
J Cyst Fibros. 2019 Nov;18(6):838-843. doi: 10.1016/j.jcf.2019.03.009. Epub 2019 Apr 30.
8
Phenotyping ciliary dynamics and coordination in response to CFTR-modulators in Cystic Fibrosis respiratory epithelial cells.在囊性纤维化呼吸道上皮细胞中,对 CFTR 调节剂做出反应,表型分析纤毛动力学和协调作用。
Nat Commun. 2019 Apr 16;10(1):1763. doi: 10.1038/s41467-019-09798-3.
9
Positive clinical response to ivacaftor treatment in an individual with the CFTR genotype F508del/V456A.携带CFTR基因F508del/V456A基因型的个体对依伐卡托治疗出现阳性临床反应。
J Cyst Fibros. 2019 Mar;18(2):e9-e10. doi: 10.1016/j.jcf.2018.10.008. Epub 2018 Oct 19.
10
VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.VX-445-泰泽卡托维瓦卡托联合治疗伴有一个或两个 Phe508del 等位基因的囊性纤维化患者。
N Engl J Med. 2018 Oct 25;379(17):1612-1620. doi: 10.1056/NEJMoa1807120. Epub 2018 Oct 18.